

Is Acyclovir still in shortage in 2026? Get the latest update on availability, cost, new options, and how to find Acyclovir at a pharmacy near you.
If you depend on Acyclovir for herpes, shingles, or another viral condition, you've probably heard the word "shortage" more times than you'd like. The question on every patient's mind is: Is Acyclovir still in shortage in 2026?
The short answer is: it depends on which form you need. The injectable (IV) form of Acyclovir has been experiencing intermittent shortages since 2020 and continues to have supply fluctuations. Oral Acyclovir — the tablets, capsules, and liquid that most patients take — is generally available, but individual pharmacies may still run out due to uneven distribution and increased demand.
In this article, we'll give you the full picture of what's happening with Acyclovir supply, what it costs in 2026, and how to make sure you can still get your medication.
Understanding how we got here helps explain the current situation:
Several factors contribute to ongoing availability challenges:
Acyclovir is an older, off-patent medication with low profit margins. Few companies are willing to invest in manufacturing it, especially the injectable form. When one manufacturer has a production issue, the entire supply chain feels it.
The number of Acyclovir prescriptions has been climbing steadily. Contributing factors include:
Even when Acyclovir is being manufactured in sufficient quantities, it doesn't reach every pharmacy equally. Large chains may get priority allocations from wholesalers, while smaller or rural pharmacies may face longer waits.
For a deeper dive into these factors, read our article on why Acyclovir is so hard to find in 2026.
One positive aspect of Acyclovir is that it remains one of the more affordable prescription medications, especially as a generic:
If you're paying out of pocket, a discount card can make a dramatic difference. Check our full guide on how to save money on Acyclovir in 2026.
While Acyclovir itself hasn't changed, the landscape around it has improved:
Getting an Acyclovir prescription has never been easier. Telehealth platforms can diagnose herpes infections and prescribe antivirals in a single virtual visit, often sending the prescription directly to a pharmacy with stock. Learn more about finding a prescriber near you.
If Acyclovir is unavailable, Valacyclovir (Valtrex) and Famciclovir (Famvir) are widely available and treat the same conditions. Valacyclovir is especially popular because it's taken less frequently and has better oral absorption. See our alternatives guide for details.
Mail-order and online pharmacies like Cost Plus Drugs, Amazon Pharmacy, and Honeybee Health often maintain better stock levels for generic medications. They can ship Acyclovir directly to your home, which is ideal for patients on daily suppressive therapy.
If you need Acyclovir today, here's what to do:
For more detailed strategies, check out our guide on how to find Acyclovir in stock near you.
The Acyclovir shortage situation in 2026 is better than it was a few years ago, but it's not fully resolved — especially for the injectable form. For oral Acyclovir, most patients can find their medication with a bit of effort, the right tools, and some flexibility.
The key is to plan ahead: don't wait until your last pill to refill, know your alternatives, and use resources like Medfinder to stay one step ahead of supply disruptions. And if cost is a barrier, discount cards and patient assistance programs can bring the price down to under $15 a month.
You deserve access to the medication you need. We're here to help you find it.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.